Moreover, METTL3 has been implicated in different acute kidney injury (AKI) models as well as in human biopsies and cultured tubular epithelial cells (TECs), and the METTL3-targeted inhibitor Cpd-564 has demonstrated efficacy in ameliorating renal dysfunction and suppressing inflammation (36). The gene discussed is METTL3; the disease is acute kidney injury.